Figure 8.Clinical features and risk factors in the validation cohort. (A) Kaplan–Meier analysis of clinical features, including age, sex, TNM stage, T stage, N stage, and M stage. (B) Kaplan–Meier analysis of clinical features in low- and high-risk subgroups.
